Does LANSOPRAZOLE Cause Focal segmental glomerulosclerosis? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Focal segmental glomerulosclerosis have been filed in association with LANSOPRAZOLE (Lansoprazole). This represents 0.1% of all adverse event reports for LANSOPRAZOLE.
55
Reports of Focal segmental glomerulosclerosis with LANSOPRAZOLE
0.1%
of all LANSOPRAZOLE reports
8
Deaths
21
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From LANSOPRAZOLE?
Of the 55 reports, 8 (14.5%) resulted in death, 21 (38.2%) required hospitalization.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANSOPRAZOLE. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does LANSOPRAZOLE Cause?
Chronic kidney disease (32,517)
Acute kidney injury (16,359)
Renal failure (12,509)
End stage renal disease (9,734)
Renal injury (9,383)
Tubulointerstitial nephritis (3,860)
Death (2,517)
Gastrooesophageal reflux disease (2,482)
Off label use (2,183)
Nephrogenic anaemia (2,162)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
MYCOPHENOLIC ACID (55)
Which LANSOPRAZOLE Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
LANSOPRAZOLE vs LANTHANUM
LANSOPRAZOLE vs LANTUS
LANSOPRAZOLE vs LANTUS SOLOSTAR
LANSOPRAZOLE vs LAPATINIB
LANSOPRAZOLE vs LAPATINIB DITOSYLATE